Ocular Therapeutix Q1 2026 Earnings EPS Misses Estimates as RD Investments Continue MS Q1 2026 Earnings Strong EPS Beat Drives Investor Optimism VNO Q1 2026 Earnings EPS Misses Estimates Amid Challenging Office Market PRG Q1 2026 Earnings EPS Surges Past Estimates by 54 TR Q3 2023 Earnings EPS of 049 Reported Stock Declines 118 Vivid Seats Q1 2026 Earnings EPS Misses Estimates Amidst Challenging Quarter